Literature DB >> 11968010

Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy.

Karin Alvarez1, Ricardo Fadic, Enrique Brandan.   

Abstract

Muscular dystrophies are characterized by continuous cycles of degeneration and regeneration that result in extensive fibrosis and a progressive diminution of muscle mass. Cell surface heparan sulfate proteoglycans are found almost ubiquitously on the surface and in the extracellular matrix (ECM) of mammalian cells. These macromolecules interact with a great variety of ligands, including ECM constituents, adhesion molecules, and growth factors. In this study, we evaluated the expression and localization of three heparan sulfate proteoglycans in the biopsies of Duchenne muscular dystrophy (DMD) patients. Through SDS-PAGE analyses followed by specific identification of heparitinase-digested proteins with an anti-Delta-heparan sulfate specific monoclonal antibodies, we observed an increase of three forms of heparan sulfate proteoglycans, corresponding to perlecan, syndecan-3, and glypican-1. Immunohistochemistry analyses indicated a differential localization for these proteoglycans: glypican-1 and perlecan were found mainly associated to ECM structures, while syndecan-3 was associated to muscle fibers. These results suggest that the amount of specific heparan sulfate proteoglycans is augmented in skeletal muscle in DMD patients presenting a differential localization. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11968010     DOI: 10.1002/jcb.10184

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  20 in total

1.  The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-β-dependent signaling, and inhibits TGF-β-dependent fibrotic response in skeletal muscles.

Authors:  Claudio Cabello-Verrugio; Cristian Santander; Catalina Cofré; Maria José Acuña; Francisco Melo; Enrique Brandan
Journal:  J Biol Chem       Date:  2011-12-27       Impact factor: 5.157

Review 2.  Stem cell-based therapies for Duchenne muscular dystrophy.

Authors:  Congshan Sun; Carlo Serra; Gabsang Lee; Kathryn R Wagner
Journal:  Exp Neurol       Date:  2019-10-19       Impact factor: 5.330

Review 3.  Syndecan-1 and Its Expanding List of Contacts.

Authors:  Mary Ann Stepp; Sonali Pal-Ghosh; Gauri Tadvalkar; Ahdeah Pajoohesh-Ganji
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-04-01       Impact factor: 4.730

4.  Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity.

Authors:  Cecilia Vial; Jaime Gutiérrez; Cristian Santander; Daniel Cabrera; Enrique Brandan
Journal:  J Biol Chem       Date:  2011-03-23       Impact factor: 5.157

5.  Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-beta and CTGF/CCN2.

Authors:  Valeria Mezzano; Daniel Cabrera; Cecilia Vial; Enrique Brandan
Journal:  J Cell Commun Signal       Date:  2008-04-15       Impact factor: 5.782

6.  Syndecans in skeletal muscle development, regeneration and homeostasis.

Authors:  Addolorata Pisconti; Jennifer D Bernet; Bradley B Olwin
Journal:  Muscles Ligaments Tendons J       Date:  2012-06-17

7.  The Emerging Roles of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 in Skeletal Muscle Redox Signaling and Metabolism.

Authors:  Carlos Henríquez-Olguín; Susanna Boronat; Claudio Cabello-Verrugio; Enrique Jaimovich; Elena Hidalgo; Thomas E Jensen
Journal:  Antioxid Redox Signal       Date:  2019-11-01       Impact factor: 8.401

8.  Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats.

Authors:  Célia M C Strunz; Monique Matsuda; Vera M C Salemi; Adriana Nogueira; Antonio P Mansur; Ismar N Cestari; Monica V Marquezini
Journal:  Cardiovasc Diabetol       Date:  2011-04-25       Impact factor: 9.951

9.  Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release.

Authors:  Ute Zacharias; Bettina Purfürst; Verena Schöwel; Ingo Morano; Simone Spuler; Hannelore Haase
Journal:  J Muscle Res Cell Motil       Date:  2011-11-05       Impact factor: 2.698

10.  Ventilatory chemosensory drive is blunted in the mdx mouse model of Duchenne Muscular Dystrophy (DMD).

Authors:  Matias Mosqueira; Santhosh M Baby; Sukhamay Lahiri; Tejvir S Khurana
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.